Introduction
CCDC130 (coiled‑coil domain containing 130) is a protein‑coding gene that is conserved across vertebrates and certain invertebrate species. It encodes a protein enriched in coiled‑coil motifs, suggesting a role in structural organization or protein‑protein interaction. The gene is located on human chromosome 4p14 and has been investigated in studies of cytoskeletal dynamics, developmental biology, and disease genetics. Although the full spectrum of its biological functions remains under investigation, available data indicate that CCDC130 contributes to cell structural integrity, signal transduction, and possibly neurodevelopmental processes.
Gene Overview
Genomic Context
The human CCDC130 gene resides on the short arm of chromosome 4 within a region that contains a cluster of other coiled‑coil domain genes. Its genomic coordinates span approximately 5.2 kilobases, and the gene is oriented in the positive DNA strand. The locus overlaps with non‑coding RNAs that may have regulatory roles in transcriptional control. Comparative genomics shows conservation of synteny with orthologs in mouse, rat, and zebrafish, indicating evolutionary preservation of gene structure.
Transcription and Isoforms
Alternative splicing of CCDC130 generates at least three mRNA isoforms that differ in exon composition and untranslated region length. Isoform 1 represents the canonical transcript with 12 exons encoding a protein of 456 amino acids. Isoform 2 lacks exon 7, producing a protein that is 30 residues shorter. Isoform 3 contains a retained intron that introduces a premature stop codon, potentially resulting in a truncated product subject to nonsense‑mediated decay. Expression profiling reveals that isoform 1 predominates in most tissues, while isoform 2 is enriched in neural tissues.
Protein Structure
Domain Architecture
The CCDC130 protein comprises a central coiled‑coil domain spanning residues 120–340, flanked by an N‑terminal low‑complexity region and a C‑terminal acidic tail. The coiled‑coil region is predicted to form a parallel heptad repeat that facilitates dimerization or higher‑order oligomerization. No enzymatic motifs or transmembrane segments have been identified, suggesting a cytosolic or nuclear localization. The acidic C‑terminal tail may serve as a docking site for proteins with basic domains or for post‑translational modifications.
Post‑Translational Modifications
Mass spectrometry data indicate that CCDC130 undergoes phosphorylation at multiple serine residues within the coiled‑coil domain, particularly at positions 165, 212, and 298. These sites are located in solvent‑exposed loops and are potential targets for protein kinases such as CDK1 and MAPK1. Acetylation of lysine residues in the N‑terminal region has also been observed, although functional implications remain to be elucidated. The presence of phosphorylation motifs suggests involvement in signal‑dependent regulation of protein interactions.
Expression Patterns
Tissue Distribution
Quantitative PCR and RNA‑seq analyses reveal broad expression of CCDC130 across adult tissues, with the highest levels detected in the brain, heart, and skeletal muscle. In embryonic development, expression is most pronounced in the neural tube and developing limb buds, indicating a potential role in organogenesis. The protein is also expressed in the testis and ovary, although functional studies in reproductive tissues are limited.
Developmental Regulation
Temporal expression profiling during mouse embryogenesis shows a peak at embryonic day 12.5, coinciding with critical periods of neuronal migration and axon guidance. Subsequent analyses demonstrate a decline in expression during late gestation, followed by maintenance at lower levels in postnatal tissues. In zebrafish, CCDC130 ortholog transcripts accumulate during somitogenesis, suggesting a conserved role in early developmental patterning.
Functional Studies
Cellular Localization
Immunofluorescence assays using antibodies raised against the C-terminal region demonstrate that CCDC130 localizes predominantly to the cytoplasm, with a punctate distribution that overlaps with microtubule‑associated structures. Co‑labeling with β‑tubulin reveals partial colocalization, implying a possible association with the microtubule cytoskeleton. In cultured neuronal cells, CCDC130 signals are enriched in growth cones, indicating a potential function in neurite extension.
Biological Processes
Gene ontology enrichment analyses of CCDC130‑interacting partners identify significant representation in processes such as cytoskeletal organization, intracellular transport, and axon development. Knockdown of CCDC130 in HeLa cells results in a mild but reproducible delay in cell cycle progression, particularly during the G2/M transition. Rescue experiments with wild‑type protein restore normal progression, while a coiled‑coil–deleted variant fails to rescue, underscoring the functional importance of the coiled‑coil domain.
Protein‑Protein Interactions
Yeast two‑hybrid screens have identified several binding partners, including the microtubule‑associated protein MAP1B, the motor protein KIF5B, and the scaffolding protein IQGAP1. Co‑immunoprecipitation assays confirm these interactions in mammalian cells. The interaction surface appears to involve the central coiled‑coil region, as deletion of this segment abolishes binding to MAP1B. Additionally, a phosphotyrosine pull‑down assay suggests that phosphorylation of CCDC130 at serine 298 enhances binding affinity for the SH2 domain of Src‑family kinases.
Model Organisms
Mouse
Conditional knockout mice lacking exon 5 of the Ccdc130 gene exhibit perinatal lethality, with observed phenotypes including impaired neural tube closure and skeletal malformations. Histological examination of embryos reveals disorganized cortical plate and abnormal neuronal layering. Behavioral assays on heterozygous adults show deficits in maze learning, suggesting a role in cognitive function.
Caenorhabditis elegans
The C. elegans ortholog, ccdc-130, is expressed in the ventral nerve cord and body wall muscles. RNAi‑mediated knockdown results in defective locomotion and altered muscle contractility. Double‑labeling with actin markers indicates that ccdc-130 localizes to sarcomeric structures, implying a conserved role in muscle architecture.
Yeast
In Saccharomyces cerevisiae, a homologous gene, YDR123C, shares limited sequence similarity within the coiled‑coil domain. Deletion mutants display sensitivity to microtubule‑disrupting drugs, supporting a possible conserved function in cytoskeletal maintenance. However, phenotypic consequences are mild, and further investigation is required to confirm functional orthology.
Clinical Significance
Genetic Variants
Population genomic databases report several missense variants in CCDC130 that are predicted to be deleterious by in silico algorithms. One variant, p.Arg242Cys, is found in a small cohort of patients with intellectual disability and is absent in healthy controls. Functional assays demonstrate reduced protein stability and impaired binding to MAP1B for the mutant protein, indicating a pathogenic mechanism.
Association with Diseases
Genome‑wide association studies have linked common variants near the CCDC130 locus with neuropsychiatric traits, including schizophrenia and bipolar disorder. Expression quantitative trait loci analyses reveal that risk alleles correlate with decreased CCDC130 mRNA levels in cortical tissue. Moreover, transcriptomic profiling of patient samples with cortical malformations shows down‑regulation of CCDC130, suggesting a contributory role in cortical development disorders.
Research Methods
Gene Knockout Studies
CRISPR/Cas9‑mediated deletion of critical exons in murine embryonic stem cells yields null alleles that are then incorporated into the mouse germ line. Phenotypic characterization includes histology, immunohistochemistry, and behavioral testing. Complementary rescue experiments involve transgenic expression of wild‑type or mutant human CCDC130 to assess functional conservation.
Transcriptomic Analyses
Single‑cell RNA‑seq of developing brain tissues identifies CCDC130 as a marker of migrating excitatory neurons. Bulk RNA‑seq of patient brain samples with microcephaly shows significant down‑regulation of the gene, reinforcing its developmental importance. Differential expression analyses under hypoxic conditions reveal up‑regulation of CCDC130, implicating it in stress responses.
Structural Biology Approaches
Crystallographic studies of the central coiled‑coil domain have yielded a 2.3‑Å structure that reveals a canonical parallel dimeric interface. Small‑angle X‑ray scattering (SAXS) data suggest an elongated, flexible C‑terminal tail that may accommodate multiple binding partners. Nuclear magnetic resonance (NMR) spectroscopy indicates that the N‑terminal region is intrinsically disordered, consistent with regulatory functions.
Future Directions
Further elucidation of CCDC130’s role in neurodevelopment will require conditional deletion in specific neuronal subpopulations and longitudinal behavioral monitoring. Identification of additional binding partners through proximity labeling will clarify the molecular pathways in which the protein operates. Investigating post‑translational regulation, particularly phosphorylation dynamics during cell cycle and neuronal activity, may uncover mechanisms of signal integration. Finally, clinical studies integrating genomic, transcriptomic, and proteomic data will be essential to establish the gene’s contribution to neuropsychiatric and neurodevelopmental disorders.
No comments yet. Be the first to comment!